Ajooni Biotech Operational Benchmarking
₹3.09+0.32%
- Market cap
- ₹53.22 crore
- P/E
- 12.3
- P/B
- 0.58
- ROE
- 4.8%
- Dividend yield
- 1.20%
Ajooni Biotech compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Ajooni Biotech sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Ajooni Biotech Limited | ₹3.09 | 12.3 | 53.22 | 1.2% | 4,500 | 4.8% |
| Median (1 Cos) | ₹3.09 | 12.3 | 53.22 | 1.2% | 4,500 | 4.8% |
Source: NSE sector index filings and financial statements. Data as of 7 October 2026. How this data is compiled.
Same Data For Peers
- Akums Drugs and Pharmaceuticals Limited operational benchmarking
- Ajanta Pharma Limited operational benchmarking
- Alivus Life Sciences Limited operational benchmarking
- Dr. Agarwal's Health Care Limited operational benchmarking
- Alkem Laboratories Limited operational benchmarking
- Advanced Enzyme Technologies Limited operational benchmarking
Trade Ajooni Biotech With ATS
Track AJOONI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.